SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-054144
Filing Date
2010-10-28
Accepted
2010-10-28 07:02:57
Documents
14
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17308_110q.htm 10-Q 1359123
2 EX-10.1 a10-17308_1ex10d1.htm EX-10.1 156433
3 EX-12.1 a10-17308_1ex12d1.htm EX-12.1 78763
4 EX-31.1 a10-17308_1ex31d1.htm EX-31.1 13379
5 EX-31.2 a10-17308_1ex31d2.htm EX-31.2 13364
6 EX-32.1 a10-17308_1ex32d1.htm EX-32.1 6644
7 EX-32.2 a10-17308_1ex32d2.htm EX-32.2 6631
8 EX-99.1 a10-17308_1ex99d1.htm EX-99.1 83636
  Complete submission text file 0001104659-10-054144.txt   5999803

Data Files

Seq Description Document Type Size
9 EX-101.INS uthr-20100930.xml EX-101.INS 909124
10 EX-101.SCH uthr-20100930.xsd EX-101.SCH 18424
11 EX-101.CAL uthr-20100930_cal.xml EX-101.CAL 50691
12 EX-101.DEF uthr-20100930_def.xml EX-101.DEF 94977
13 EX-101.LAB uthr-20100930_lab.xml EX-101.LAB 267587
14 EX-101.PRE uthr-20100930_pre.xml EX-101.PRE 128783
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 101146274
SIC: 2834 Pharmaceutical Preparations